Structural biology of insulin and IGF-1 receptors

Novartis Foundation Symposium

Volumn 262, Issue , 2004, Pages 160-176

  De Meyts, Pierre ^a   Palsgaard, Jane ^a   Sajid, Waseem ^a   Theede, Anne Mette ^a   Aladdin, Hassan ^a   Roberts, ^b   Thomas, ^b   Pollak, ^b  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR;

ANIMAL; CHEMISTRY; HUMAN; REVIEW;

ANIMALS; HUMANS; RECEPTOR, INSULIN; RECEPTORS, GROWTH FACTOR;

EID: 16544390736     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (64)

1. Adams TE, EPA VC, Garrett TP, Ward CW 2000 Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093
2. Avruch J 2001 Receptor tyrosine kinases. In: De Groot LJ, Jameson JL (eds) Endocrinology. 4th edn. WB Saunders Co, Philadelphia, p 25-47
3. Baker EN, Blundell TL, Cutfield JF et al 1988 The structure of 2Zn pig insulin at 1.5 Å resolution. Phil Trans R Soc Lond B19:369-456
4. Barbieri M, Bonafé M, Franceschi C, Paolisso G 2003 Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 285:E1064-E1071
5. Blume-Jensen P, Hunter T 2001 Oncogenic kinase signalling. Nature 411:355-365
6. Brandt J, Andersen AS, Kristensen C 2001 Dimeric fragment of the insulin receptor alpha-subunit binds insulin with full holoreceptor affinity. J Biol Chem 276:12378-12384
7. Brunelleschi S, Penengo L, Santoro MM, Gandino G 2002 Receptor tyrosine kinases as target for anti-cancer therapy. Curr Pharm Des 8:1959-1972
8. Brzozowski AM, Dodson EJ, Dodson GG et al 2002 Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry 41:9389-9397
9. Christoffersen CT, Bornfeldt KE, Rotella CM et al 1994 Negative cooperativity in the insulin-like growth factor-I (IGF-I) receptor and a chimeric IGF-I/insulin receptor. Endocrinology 135:472-475
10. De Meyts P 1994 The structural basis of insulin and insulin-like growth factor-I (IGF-I) receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 37:S135-S148
11. De Meyts P, Whittaker J 2002 Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1:769-783
12. De Meyts P, Van Obberghen E, Roth J, Brandenburg D, Wollmer A 1978 Mapping of the residues of the receptor binding region of insulin responsible for the negative cooperativity. Nature 273:504-509
13. De Meyts P, Gu JL, Shymko RM, Kaplan BE, Bell GI, Whittaker J 1990 Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene. Mol Endocrinol 4:409-416
14. Drevs J, Medinger M, Schmidt-Gersbach C, Weber R, Unger C 2003 Receptor tyrosine kinases: the main targets for new anticancer therapy. Curr Drug Targets 4:113-121
15. Fabry M, Schaefer E, Ellis L, Kojro E, Fahrenholz F, Brandenburg D 1992 Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem 267:8950-8956
16. Favelyukis S, Till JH, Hubbard SR, Miller WT 2001 Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol 8:1058-1063
17. Frasca F, Pandini G, Scalia P et al 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288
18. Garrett TP, McKern NM, Lou M et al et al 1998 Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394:395-399
19. Gray SG, Stenfeldt Mathiasen I, De Meyts P 2003 The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm Metab Res 35:857-871
20. Heldin CH, Ostman A 1996 Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev 7:3-10
21. Holst PA 2000 Interaction of insulin and insulin analogues with the insulin receptor: relationship between structure, binding kinetics and biological function. PhD thesis, Copenhagen University, Copenhagen, Denmark
22. Hsu SY 2003 New insights into the evolution of the relaxin-LGR signaling system. Trends Endocrinol Metab 14:303-309
23. Hua XH, Shoelson SE, Kochoyan M, Weiss M 1991 Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354:238-241
24. Hubbard SR 1997 Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16:5572-5581
25. Hubbard SR, Till JH 2000 Protein tyrosine kinase structure and function. Ann Rev Biochem 69:373-398
26. Hubbard SR, Weiss L, Ellis L, Hendrickson WA 1994 Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-754
27. Jensen AM 2001 Analysis of structure-activity relationships of the insulin molecule by alanine-scanning mutagenesis. Master's thesis, Copenhagen University, Copenhagen, Denmark
28. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW 2003 Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53
29. Kadowaki H, Kadowaki T, Cama A et al 1990 Mutagenesis of lysine 460 in the insulin receptor. Effects on receptor recycling and cooperative interactions among binding sites. J Biol Chem 265:21285-21296
30. Kristensen C, Andersen AS, Hach M, Wiberg FC, Schäffer L, Kjeldsen T 1995 A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. Biochem J 305:981-986
31. Kristensen C, Kjeldsen T, Wiberg FC et al 1997 Alanine scanning mutagenesis of insulin. J Biol Chem 272:12978-12983
32. Kristensen C, Wiberg FC, Schäffer L, Andersen AS 1998 Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. Minimizing ligand binding domain of the insulin receptor. J Biol Chem 273:17780-17786
33. Kristensen C, Andersen AS, Ostergaard S, Hansen PH, Brandt J 2002 Functional reconstitution of insulin receptor binding site from non-binding receptor fragments. J Biol Chem 277:18340-18345
34. Levitzki A 2002 Tyrosine kinases as targets for cancer therapy. Eur J Cancer 38:S11-S18
35. Loren CE, Englund C, Grabbe C, Hallberg B, Hunter T, Palmer RH 2003 A crucial role for the anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster. EMBO Rep 4:781-786
36. Ludvigsen S, Olsen HB, Kaarsholm NC 1998 A structural switch in a mutant insulin exposes key residues for receptor binding. J Mol Biol 279:1-7
37. Macaulay 2004 The IGF receptor as anti-cancer treatment target. In: Biology of IGF-1: its interaction with insulin in health and malignant states (Novartis Found Symp 262). Wiley, Chichester, p 235-246
38. Mynarcik DC, Williams PF, Schäffer L, Yu GQ, Whittaker J 1997 Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B chain of the insulin molecule. J Biol Chem 272:2077-2081
39. Nakagawa SH, Tager HS 1992 Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Biochemistry 31:3204-3214
40. Nakagawa SH, Tager HS, Steiner DF 2000 Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Biochemistry 39:15826-15835
41. Palsgaard J 2003 Receptor-binding properties of 25 different hystricomorph-like human insulin analogs. Master's thesis, Copenhagen University, Copenhagen, Denmark
42. Pillutla RC, Hsiao KC, Beasley JR et al 2002 Peptides identify the critical hotspots involved in the biological activation of the insulin receptor. J Biol Chem 277:22590-22594
43. Piron MA 1981 Etude des relations entre la structure et la fonction de l'insuline chez les Vertébrés. PhD thesis, Catholic University of Louvain, Brussels, Belgium
44. Pullen RA, Lindsay DG, Wood SP et al 1976 Receptor-binding region of insulin. Nature 259:369-373
45. Robertson SC, Tynan JA, Donoghue DJ 2000 RTK mutations and human syndromes. When good receptors turn bad. Trends Genet 16:265-271
46. Robinson DR, Wu YM, Lin SF 2000 The protein tyrosine kinase family of the human genome. Oncogene 19:5548-5557
47. Schäffer L 1994 A model for insulin binding to the insulin receptor. Eur J Biochem 221:1127-1132
48. Schäffer L, Brissette RE, Spetzler JC et al 2003 Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks. Proc Natl Acad Sci USA 100: 4435-4439
49. Seino S, Bell GI 1989 Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159:312-316
50. Seino S, Seino M, Nishi S, Bell GI 1989 Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86:114-118
51. Soos M, Field CE, Siddle K 1993 Purified hybrid insulin/insulin-like growth factor-i receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290:419-426
52. Surinya KH, Molina L, Soos MA, Brandt J, Kristensen C, Siddle K 2002 Role of insulin receptor dimerization domains in ligand binding, cooperatively, and modulation by anti-receptor antibodies. J Biol Chem 277:16718-16725
53. Taylor SI, Cama A, Accili D et al 1992 Mutations in the insulin receptor gene. Endocr Rev 13:566-595
54. Tulloch PA, Lawrence LJ, McKern NM et al 1999 Single-molecule imaging of human insulin receptor ectodomain and its Fab complexes. J Struct Biol 125:11-18
55. Vajdos FF, Ultsch M, Schaffer ML et al 2001 Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions. Biochemistry 40:11022-11029
56. Van den Brande JL 1992 Structure of human insulin-like growth factors: relationship to function. In insulin-like growth factors. Structure and biological functions. Oxford University Press, Oxford
57. Walenkamp MJE, Pereira Arias AM, Sluimers C et al 2003 Biochemical features of a 55 year old man with a homozygous missense mutation of IGF-1 and of his heterozygous relatives. Horm Res 60 (suppl 2):15
58. Whittaker J, Groth AV, Mynarcik DC, Pluzek L, Gadsboll VL, Whittaker LJ 2001 Alanine scanning mutagenesis of a type 1 insulin-like growth factor receptor ligand binding site. J Biol Chem 276:43980-43986
59. Williams PF, Mynarcik DC, Yu GQ, Whittaker J 1995 Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis. J Biol Chem 270:1-5
60. Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO 2000 Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 85:1407-1411
61. Yip CC, Hsu H, Patel RG, Hawley DM, Maddux BA, Goldfine ID 1988 Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Biochem Biophys Res Commun 157:321-329
62. Yip CC, Ottensmeyer P 2003 Three-dimensional structural interactions of insulin and its receptor. J Biol Chem 278:27329-27332
63. Zhang B, Roth RA 1991 A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci USA 88:9858-9862
64. Zwick E, Bange J, Ullrich A 2002 Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol Med 8:17-23